Global trends in drug trafficking and drug usage patterns indicate a contin
uing pattern of escalation throughout the world. Over the last two decades,
urinalysis has evolved into a highly accurate means for determining whethe
r individuals have been exposed to illicit drugs of abuse. Advances have al
so been made in the use of alternate biological matrices such as hair, oral
fluids and sweat for drug testing. Often, these new matrices demonstrate s
ome distinct advantages over urinalysis, e.g. less invasive procedures, dif
ferent time course of drug detection. They may even indicate impairment. Na
tional and local laws of each country provide the underpinnings of drug-tes
ting programs, but most countries have not addressed use of these alternate
matrices. Currently, only a few countries have statutes that specifically
mention use of alternate biological matrices, e.g. United States (Florida s
tate law), Germany, Ireland, Poland and the Czech Republic. Conversely, few
countries have prohibited collection of alternate biological specimens or
drug test devices that utilize such specimens. In addition, guidelines for
implementing drug testing pro-rains have been slow to emerge and most deal
primarily with workplace drug testing programs, e.g. United States. Current
ly, scientific technology utilized in drug testing is advancing rapidly, bu
t there is a clear need for parallel development of guidelines governing th
e use of alternate matrices for drug testing. This article provides an over
view of global drug trafficking patterns and drug use, and results from a s
urvey of legal statutes in 20 countries covering use of alternate matrices
for drug testing. In addition, elements needed for the development of guide
lines for alternate matrices testing for drugs of abuse are discussed, and
specific examples of use of alternate matrices in treatment monitoring are
provided. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.